Glut1 is required for glucose uptake and proliferation. Although the expression of Glut1 in keratinocytes is well established, the regulation of Glut1 and the expression of additional glucose transporters in the skin has not been explored. Immunofluorescence revealed that Glut1 was primarily expressed in the more proliferative basal Proliferating cells, compared with quiescent cells, are more dependent on glucose for their growth. Although glucose transport in keratinocytes is mediated largely by the Glut1 facilitative transporter, we found that keratinocyte-specific ablation of Glut1 did not compromise mouse skin development and homeostasis. Ex vivo metabolic profiling revealed altered sphingolipid, hexose, amino acid, and nucleotide metabolism in Glut1-deficient keratinocytes, thus suggesting metabolic adaptation. However, cultured Glut1-deficient keratinocytes displayed metabolic and oxidative stress and impaired proliferation. Similarly, Glut1 deficiency impaired in vivo keratinocyte proliferation and migration within wounded or UV-damaged mouse skin. Notably, both genetic and pharmacological Glut1 inactivation decreased hyperplasia in mouse models of psoriasis-like disease. Topical application of a Glut1 inhibitor also decreased inflammation in these models. Glut1 inhibition decreased the expression of pathologyassociated genes in human psoriatic skin organoids. Thus, Glut1 is selectively required for injury-and inflammation-associated keratinocyte proliferation, and its inhibition offers a novel treatment strategy for psoriasis.
G lucose is a preferred bioenergetic and synthetic substrate for rapidly proliferating cells. However, recent studies have begun to highlight the diverse array of metabolic substrates that cells can use to promote growth. For example, although cancer cells consistently show a high capacity to utilize glucose as a metabolic substrate 1 , they are capable of using diverse substrates (for example, amino acids, acetate, and lactate) for energy generation and anabolic growth in vivo [2] [3] [4] [5] [6] . In some tissues, the preferential utilization of glycolysis has been linked to cell phenotype. For example, increased Glut1 expression and glucose utilization promote effector T cell function, whereas fatty acid oxidation (FAO) promotes regulatory CD4 + T cell and memory CD8 + T cell fates 7, 8 . In endothelial cells, glycolysis promotes vessel branching and migration, whereas FAO is required for proliferation 9, 10 . Thus, tissue functions are regulated in part through the controlled flow of metabolic substrates.
The facilitative glucose transporter (Glut) proteins regulate the availability of glucose in most tissues. The 13 Glut family members are regulated in a tissue-and stimulus-specific fashion, thus suggesting that they have important roles in shaping or maintaining cell function 11 . Glut1, the most widely expressed facilitative glucose transporter, regulates basal glucose uptake in most tissues 12 , including the basal cells of the epidermis 13 . In agreement with a role in promoting keratinocyte proliferation, Glut1 expression is increased in wound healing, in psoriatic plaques, or after UV-induced hyperplasia [14] [15] [16] . However, the precise role of Glut1 and glucose transport in regulating keratinocyte function has not been definitively characterized.
Here, we specifically deleted Glut1 in keratinocytes to determine how glucose metabolism affects epidermal development and function. In agreement with its known role in energy generation and biosynthesis, Glut1-deficient keratinocytes showed markedly impaired proliferation in vitro. Nonetheless, Glut1 deficiency had no effect on epidermal development or function in vivo. Gene expression analyses, metabolic profiling, and in vitro rescue experiments revealed that alternative hexoses, amino acid catabolism, and FAO all contributed to metabolic programs that allowed for epidermal function in the absence of Glut1. However, Glut1 deficiency impaired the physiological proliferation triggered by full-thickness wounds and UV irradiation, and genetic or chemical inhibition of Glut1 rendered the skin resistant to imiquimod-or IL-23-induced psoriasiform hyperplasia. Our results indicate that glucose metabolism is selectively essential for proliferating keratinocytes, highlighting a potential therapeutic target for pathological hyperproliferation.
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NATUrE MEdiciNE layers of both human and mouse skin ( Supplementary Fig. 1a ). In agreement with the reported role of Glut1 in cell proliferation, the expression of Glut1 was high in undifferentiated keratinocytes but decreased after either Ca 2+ -or confluence-induced differentiation ( Supplementary Fig. 1b,c) . The mRNA expression of other facilitative (Glut1-Glut13 (official symbols Slc2a1-Slc2a13)) and sodiumdependent glucose transporters (Sglt1 and Sglt2 (official symbols Slc5a1 and Slc5a2) in mouse epidermis, mouse and human primary keratinocytes, immortalized human keratinocytes (HEK001), and squamous cell cancers was assessed 17 ; only Glut1 was highly expressed ( Supplementary Fig. 1d-h ). Next, Glut1 was deleted in epidermal keratinocytes by crossing Glut1 fl/fl mice to K14-Creexpressing mice 18 . In those mice (hereafter denoted K14. Glut1 ), compared with their Glut1 fl/fl (hereafter denoted WT) littermates, Glut1 mRNA expression was > 95% lower in both the epidermis and primary cultured keratinocytes. Western blotting and immunofluorescence confirmed that Glut1 was undetectable in the epidermis of K14.Glut1 mice (Fig. 1a,b and Supplementary Fig. 1i,j) . Quantitative RT-PCR revealed no significant compensatory upregulation of any other glucose transporters in keratinocytes from K14.Glut1 mice ( Fig. 1c ). 3 H-labeled 2-deoxyglucose (2-DG) uptake assays in primary Glut1-deficient keratinocytes confirmed that Glut1 deletion blocked glucose transport. 2-DG uptake was ~96% lower in keratinocytes from K14.Glut1 mice compared with their WT littermates. The residual low level of glucose uptake in keratinocytes from K14.Glut1 mice was comparable to passive levels of transport, which occurred in the presence of chemical inhibitors of glucose transport ( Fig. 1d ).
Because Glut1 plays important roles in cell proliferation 19, 20 , we tested whether keratinocytes from K14.Glut1 mice showed defects in proliferation. The growth of primary Glut1-deficient keratinocytes was markedly impaired compared with that of WT keratinocytes, on the basis of crystal violet staining and cell numbers ( Fig. 1e ). GLUT1 was also essential for proliferation in human keratinocytes in vitro. The chemical inhibition of glucose transport through treatment with an established inhibitor of glucose transport, WZB117 (ref. 21 ), compared with vehicle control, impaired glucose uptake and significantly slowed cell growth ( Supplementary Fig. 2a,b ). In agreement with the results from the 2-DG uptake studies, keratinocytes from K14.Glut1 mice consumed less glucose and produced less lactate (~5%) than did their WT counterparts ( Fig. 1f ). ATP levels were also significantly lower in these keratinocytes ( Fig. 1g ). Decreased ATP levels can cause energetic stress and activate the 5′ -AMP-activated protein kinase. Indeed, downstream targets of this kinase, such as acetyl-CoA carboxylase 1 (ACC) showed increased phosphorylation in the knockout keratinocytes. In agreement with this energetic stress, phosphorylation of S6 ribosomal protein, a target of the mTOR kinase and a growth-promoting pathway, was inhibited in the keratinocytes from K14.Glut1 mice compared with WT controls (Fig. 1h ).
Glut1 contributes to redox homeostasis.
To discover additional pathways contributing to the impaired proliferation under glucose deficiency, we performed microarray analysis on keratinocytes from K14.Glut1 mice and their WT littermates (GSE102955; Fig. 2a and Supplementary Fig. 3a ). In agreement with the significantly lower proliferative capacity of keratinocytes from Glut1-deficient mice, compared with their WT littermates, hierarchical clustering and gene ontology analyses revealed that the expression of genes related to cell-cycle progression and cell division was markedly impaired. Normal cells respond to oxidative stress by routing glucose through the pentose phosphate pathway (PPP) to regenerate NADPH 22, 23 . In agreement with glucose's role in the clearance of reactive oxygen species (ROS), transcripts related to redox homeostasis were among the genes with the most elevated expression in keratinocytes from K14. Glut1 compared with WT mice ( Fig. 2a and Supplementary Fig. 3a) .
Twenty-four genes related to oxidative stress showed more than twofold-higher expression in Glut1-deficient keratinocytes than in WT keratinocytes ( Fig. 2b and Supplementary Fig. 3b ). Other oxidative-stress-response genes including Nqo1 and Hmox1 (also known as HO1) were significantly upregulated in Glut1-deficient keratinocytes compared with WT keratinocytes, both under basal growth conditions and when cells were treated with H 2 O 2 or UV-B ( Fig. 2c,d ). Confirming the effect of Glut1 on cellular levels of oxidative stress, fluorescence measurements of the ROS indicator DCFDA revealed that keratinocytes from K14.Glut1 mice, compared with WT keratinocytes, showed significantly higher levels of ROS both under basal growth conditions and after treatment with H 2 O 2 or UV-B ( Fig. 2e ). Glut1-deficient keratinocytes, compared with WT keratinocytes, were significantly more sensitive to H 2 O 2and UV-B-induced cell death, even after controlling for their slower growth ( Fig. 2f ). Supplementation with antioxidants (glutathione (GSH) or N-acetylcysteine (NAC)) rescued H 2 O 2 -induced toxicity in keratinocytes from K14.Glut1 mice (Fig. 2g ). In primary human keratinocytes, the acute inhibition of GLUT1 through WZB117 also increased the sensitivity of the cells to H 2 O 2 ( Supplementary  Fig. 2c ) and increased the expression of redox-homeostasis genes ( Supplementary Fig. 2d ). Both genetic and chemical inhibition of glucose transport lowered levels of NADPH, as compared with those after treatment with their respective controls ( Fig. 2h and Supplementary Fig. 2e ,f), thus suggesting that decreased flux through the PPP contributed to the observed defects in redox homeostasis. MitoSOX mitochondrial superoxide staining further revealed that acute (but not chronic) chemical inhibition of glucose transport, as compared with control vehicle treatment, increased mitochondrial oxidative stress ( Supplementary Fig. 2g ), thus suggesting that mitochondria may be an additional source of oxidative stress in keratinocytes deprived of glucose. Despite Nrf2's established role in mediating the response to oxidative stress 24 , the total and nuclear levels of Nrf2 were not higher in keratinocytes from K14.Glut1 mice ( Supplementary Fig. 4a,b ). Thus, Glut1 is required for redox homeostasis in keratinocytes at least in part through its roles in regenerating NADPH.
Glut1 is not essential for normal skin development. Given the striking effect of Glut1 deletion on keratinocyte growth, we assessed the in vivo effects of Glut1 deletion. Notably, K14.Glut1 mice appeared normal: we observed no abnormalities in the skin of young or adult K14.Glut1 mice relative to their WT littermates ( Supplementary Fig. 5a ). Both male and female K14.Glut1 mice showed normal skin histology at 1 week and 2 months (Fig. 3a) . The expression and localization of epidermal keratins (K10 and K14) ( Fig. 3b and Supplementary Fig. 5b-d ), loricrin ( Supplementary  Fig. 5e ), and differentiation and adhesion genes ( Fig. 3c ) showed no differences between WT and K14.Glut1 littermates, thus suggesting normal epidermal differentiation.
Given previous reports that glycosylated ceramides and UDP-glucose are essential intermediates for epidermal ceramide maturation, lamellar body formation, and stratum corneum development 25, 26 , we performed an analysis of epidermal lipids. Liquid chromatography-tandem mass spectrometry (LC-MS/MS) revealed that the epidermis of K14.Glut1 mice, compared with WT, showed unchanged levels of phospholipids, lower levels of free ceramides and sphingoidbases, and higher levels of sphingomyelins ( Fig. 3d , Supplementary  Fig. 5f and Supplementary Dataset 1). Notably, hexosylceramide levels were significantly lower in the keratinocytes from K14.Glut1 mice but not in the epidermis of K14.Glut1 neonatal mice, as compared with WT levels (Fig. 3e ). Moreover, K14.Glut1 and WT mice showed no significant differences in weight either as pups or adults ( Fig. 3f ). Compared with WT embryos, K14.Glut1 embryos showed both normal toluidine blue-exclusion assay results ( Fig. 3g ) and no defects in transepidermal water loss, as assessed by a weight Articles NATUrE MEdiciNE time-course analysis of newborn mice ( Fig. 3h ). Finally, in contrast to the previously described defects in redox homeostasis, Glut1deficient epidermis showed no marked alterations in the expression of redox-homeostasis genes or evidence of energetic stress, as determined by western blot analyses ( Supplementary Fig. 5g ,h). Thus, although keratinocytes from K14.Glut1 mice showed marked alterations in lipid metabolism, redox homeostasis, and energetic stress in vitro, these defects were rescued in vivo, thus allowing for normal skin development.
Metabolic compensation for Glut1 deficiency. To gain insight into how K14.Glut1 mice adapted to the loss of glucose uptake, neonatal epidermis was harvested for analysis of intracellular metabolites by LC-MS/MS (Supplementary Dataset 2). Principal component analysis showed different metabolic profiles for the epidermis from K14. Glut1 mice and WT mice ( Supplementary Fig. 6a ). Quantitative pathway enrichment analysis of epidermal metabolites from Glut1-deficient mice, compared with their littermate controls, revealed a significant enrichment in several expected pathways including nucleotide sugar metabolism, the tricarboxylic acid (TCA) cycle, and the PPP ( Supplementary Fig. 6b ). Significantly lower levels of numerous metabolites, including glucose-6-phosphate (G6P), lactate, aconitate, malate, and fumarate, confirmed the expected impairments in glycolysis and the TCA cycle ( Fig. 4a ). Metabolomics also revealed significant changes in amino acid metabolism and the urea cycle, including changes in glutamine, cystathionine, citrulline, carbamoyl phosphate, and acetylornithine ( Fig. 4b ). In agreement with the increased catabolism of amino acids, the expression of numerous amino acid transporters was significantly higher in keratinocytes from K14.Glut1 mice compared with WT controls ( Supplementary Fig. 6c ). Finally, Glut1 deletion also affected nucleotide metabolism, as evidenced by lower levels of UMP and dAMP and higher levels of allantoin in the epidermis in K14.Glut1 mice compared with WT controls (Fig. 4c ). 
Fig. 1 | Primary keratinocytes showed impaired proliferation after Glut1 deletion. a, Glut1 mRNA (n = 4 mice per genotype) and protein levels in the epidermis and primary keratinocytes harvested from 1-week-old WT, K14.Glut1 fl/WT , and K14.Glut1 mice. HSP90, loading control. b, Immunostaining of Glut1 in skin from 1-week-old mice. Glut1 staining is absent in epidermis from K14.Glut1 mice. Arrows indicate persistence of Glut1 staining in the dermis (for example, dermal endothelial cells). DAPI, nuclear stain. Similar results were obtained in three independent experiments. Scale bar, 10 μ m. c, mRNA abundance for the indicated Glut and SGLT family members in primary cultured keratinocytes from WT, Glut1 fl/WT K14Cre , and K14.Glut1 mice (n = 4 mice per genotype). d, 2-Deoxy-d-glucose uptake in primary cultured keratinocytes obtained from 1-week-old WT, K14.Glut1 fl/WT , and K14.Glut1 mice with or without glucose-inhibitor pretreatment. Similar results were obtained in uptake assays from keratinocytes from three independent mice. CPM, counts per minute. e, Growth rate, as assessed by crystal violet staining and relative cell number for primary keratinocytes from WT, K14.Glut1 fl/WT , and K14. Glut1 mice. Identical numbers of cells were seeded in triplicate wells in six-well plates at day 0. For crystal violet staining, cells were stained 3 d after seeding, and similar results were obtained for three keratinocyte preparations. Keratinocytes from K14.Glut1 mice showed significantly less growth than did keratinocytes from WT controls at days 1 and 2 after plating. f, Glucose consumption and lactate production over 12 h, as measured in the medium of primary cultured WT and K14.Glut1 (n = 3 mice per genotype) keratinocytes. g, ATP levels (luminescence; AU, arbitrary units) determined in primary keratinocytes from WT and K14.Glut1 (n = 3 mice per genotype) and normalized to protein levels. h, Western blot analysis of the expression of p-ACC Ser79, ACC, p-S6 Ser240/244, CoxIV, and Glut1 in primary keratinocytes obtained from WT, Glut1 fl/WT K14Cre , and K14.Glut1 mice. Data are shown as mean ± s.d. P values were calculated with two-tailed t test. Results were confirmed in at least two independent experiments.
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Metabolic profiling highlighted changes in galactose metabolism in the epidermis of K14.Glut1 mice. Intracellular galactose-1-phosphate was maintained at similar levels as G6P and fructose-6-phosphate and was depleted to similar levels as G6P and fructose-6-phosphate in the epidermis of K14.Glut1 mice, thus suggesting that it was actively metabolized in the epidermis (Fig. 4a ). Moreover, the keratinocytes expressed Glut5, SGLT1 ( Supplementary Fig. 1d ,e), and ketohexokinase, which should have allowed for fructose metabolism to occur. Therefore, we tested whether galactose and fructose could rescue the growth of Glut1deficient keratinocytes. In keratinocytes from Glut1-deficient mice compared with WT mice, fructose and galactose significantly improved keratinocyte growth (Fig. 4e,f and Supplementary  Fig. 7a ,b), ATP levels ( Fig. 4g ), expression of redox-homeostasis genes (Fig. 4h ), and resistance to H 2 O 2 (Fig. 4i ). Fructose almost fully rescued the growth and oxidative-stress defects of keratinocytes from K14.Glut1 mice, whereas galactose was less effective. Because FAO contributes reducing equivalents and acetyl-CoA in endothelial cell metabolism 10 , we tested whether mixtures of oleate and palmitate could rescue the growth of Glut1-deficient keratinocytes. The addition of up to 10 μ M of a fatty acid mixture partially rescued the growth of keratinocytes from K14.Glut1 mice and increased ATP production in both Glut1-deficient and WT keratinocytes ( Fig. 4j,k) . In contrast, neither a myriad of downstream metabolites and antioxidants (including pyruvate, lactate, amino acids, GSH, NAC, glutamine, or ribose), supplemented individually or in combination ( Supplementary Fig. 7c -h), nor growth under hypoxic conditions ( Supplementary Fig. 7i ) was able to rescue Glut1-deficient keratinocyte growth in vitro. In summary, keratinocytes can utilize galactose, fructose, and fatty acids as metabolic substrates to promote growth in the absence of Glut1 ( Supplementary Fig. 7j ).
Glut1 is required for stress responses in vivo. We next tested whether Glut1 was necessary for the epidermal responses to physiological stress. One critical function of human skin is protection from UV irradiation. Chronic irradiation has been reported to promote both Glut1 expression and acanthosis 16 . We shaved and Survival is plotted as the ratio of the number of surviving cells to the number of plated cells per genotype without H 2 O 2 treatment (n = 3 mice per group). g, Keratinocytes were pretreated with GSH or NAC, then incubated with H 2 O 2 for 24 h. Survival is plotted relative to that of untreated controls (n = 3 mice). h, Keratinocytes from K14.Glut1 mice, showing significantly lower levels of NADPH (n = 4 mice per genotype). Data are shown as mean ± s.d. P values (indicated above relevant comparisons) were calculated with two-tailed t test (b,h), two-way analysis of variance (ANOVA) with Tukey's tests (c-e), and one-way ANOVA with Dunnett tests (g). Results were confirmed in at least 2 independent experiments.
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UV-B-irradiated K14.Glut1 mice and WT littermates to determine the role of glucose transport in the acute and delayed response to UV-B ( Supplementary Fig. 8a ). There were no obvious macroscopic or histologic differences in the skin of K14.Glut1 mice compared with their WT littermates 24 h after UV-B treatment ( Fig. 5a and Supplementary Fig. 8a,b ). UV-B induced similar significant increases in skin thickness in both WT and K14.Glut1 mice ( Supplementary Fig. 8c ). TUNEL staining for apoptotic keratinocytes also showed no differences in the skin between WT and K14. Glut1 mice ( Supplementary Fig. 8d,e ). By 5 d after UV-B treatment, the WT mice had largely recovered and showed regular acanthosis, whereas many areas of skin from the K14.Glut1 mice showed areas of abnormal stratification with areas of keratinocyte necrosis ( Fig. 5a and Supplementary Fig. 8b ). Although nonirradiated epidermis did not show differences in redox-homeostasis genes, 6 h after UV-B treatment, epidermis from Glut1-deficient mice, compared with WT controls, showed a modest but significant upregulation of oxidative-stress-response genes. These changes were no longer significant 24 h after UV-B treatment ( Fig. 5b and Supplementary Figs. 5g and 8f ). Significantly fewer Ki-67 + cells were present in the epidermis of K14.Glut1 mice compared with WT controls (Fig. 5c,d) . These defects in proliferation were corroborated by elevated staining of phosphorylated (p-) ACC Ser79 and decreased staining of p-S6 Ser240/244 in the skin in Glut1deficient mice compared with WT controls after UV-B treatment ( Supplementary Fig. 8e ). Keratinocytes secrete inflammatory cytokines in response to UV-B 27 , and these cytokines contribute to the physiological response to irradiation. UVB-induced inflammation, 
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as assessed by expression of the cytokines IL-1β , TNFα , IL-6, and IFNγ , revealed no significant differences between littermates ( Supplementary Fig. 8h ). In summary, compared with WT mice, K14.Glut1 mice showed impairments in redox homeostasis, proliferation, and recovery after UV-B treatment.
The epidermis also undergoes rapid proliferation in response to wounds. To understand the role of Glut1 in wound repair, we assessed the recovery of mice from splinted 3-mm excisional wounds ( Supplementary Fig. 9a ). Reepithelialization was assessed after 5.5 and 8 d. Both K14. Glut1 and WT mice exhibited lymphohistiocytic infiltrates around the wound edge ( Supplementary Fig. 9b ). However, healing in the K14.Glut1 mice, compared with their WT littermates, was significantly impaired at both time points (Fig. 5e,f) . Specifically, by day 8, the WT mice had largely completed wound healing, whereas all the K14.Glut1 mice still exhibited persistent epidermal defects ( Fig. 5e and Supplementary Fig. 9b ). Keratinocyte migration and proliferation both contribute to wound healing 28 . To study cell migration in Glut1-deficient keratinocytes, we analyzed keratinocyte migration in scratch assays through timelapse microscopy. Keratinocytes from K14.Glut1 mice, compared 
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with WT littermates, showed significantly delayed scratch closure (Fig. 5g,h and Supplementary Videos 1 and 2) . To address the role of proliferation in reepithelialization, we assessed the histology of the wound edge. Wounds in K14.Glut1 mice, compared with WT controls, had significantly fewer Ki-67 + cells within 500 μ m of the wound edge ( Supplementary Fig. 9c ). In agreement with these in vitro proliferative defects, the excisional wounds of K14.Glut1 mice also showed elevated staining of p-ACC Ser79 and lower staining of p-S6 Ser240/244 ( Supplementary Fig. 9e ).
Glucose-transport inhibition ameliorates psoriasis models.
Although keratinocyte hyperproliferation can be triggered as a protective response against physiological insult, it can also be triggered pathologically. Psoriasis is a chronic cytokine-driven, inflammatory skin disease characterized by hyperplasia and abnormal differentiation of the epidermis that presents as thickened and scaly plaques. After confirming that GLUT1 transcription and expression were elevated in lesional biopsies from people with psoriasis ( Supplementary  Fig. 10a -c), we tested whether Glut1 deletion might affect the development of pathological hyperplasia in diseases such as psoriasis. We established psoriasiform hyperplasia in WT and K14.Glut1 mice through two models: topical application of imiquimod 29, 30 and intradermal injection of IL-23 (ref. 31 ). The skin of WT mice treated with imiquimod showed upregulated Glut1 expression ( Supplementary  Fig. 10a,d,e ) and acanthosis ( Supplementary Fig. 10a ). In contrast, the epidermis of K14.Glut1 mice was markedly protected from imiquimod-induced psoriasiform hyperplasia ( Fig. 6a and Supplementary  Fig. 10g ). To extend the translational relevance of these findings, we tested whether the topical inhibition of glucose transport might also prevent the development of psoriasiform hyperplasia ( Supplementary  Fig. 10f ). In both mouse models of psoriasiform hyperplasia, treatment with the topical GLUT inhibitor WZB117, compared with vehicle control, decreased scale ( Fig. 6a and Supplementary Fig. 10g,h) and significantly inhibited skin thickening (Fig. 6b,c Articles NATUrE MEdiciNE Fig. 10h ). The skin of K14.Glut1 mice and WZB117-treated WT mice showed lower Ki-67 staining than that of vehicle-treated WT controls (Fig. 6d,e ). Western blotting confirmed that the skin of both Glut1-deficient mice and WZB117-treated mice showed elevated p-ACC and lower p-S6 Ser240/Ser244 levels, results consistent with energetic stress ( Supplementary Fig. 10i ). 
and Supplementary
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In addition to inducing keratinocyte proliferation, imiquimod also induces the accumulation of leukocytes in the skin, including neutrophils, macrophages, dendritic cells, and T cells 30, 32, 33 . We examined the effect of inhibition of glucose transport on inflammation through immunohistochemistry (IHC) staining. Topically applied WZB117 significantly decreased the numbers of leukocytes (CD45 + ), neutrophils (Gr-1 + ), macrophages (F4/80 + ), and T cells (CD4 + ), but not dendritic cells (CD11c), localized to the skin after treatment with imiquimod compared with vehicle control. In contrast, the skin of K14.Glut1 mice showed significant decreases in only T cell number (CD4 + ) after imiquimod treatment ( Fig. 6f and Supplementary Fig. 11a-f) . Similarly, the mRNA levels of several cytokines (CCL3, CXCL3, and IL-1β ) that are upregulated in imiquimod-induced psoriasiform dermatitis 34 showed significant decreases in WT mice topically treated with WZB117; however, the levels in the K14.Glut1 mice were not significantly different from those in vehicle-control-treated WT mice ( Supplementary  Fig. 11g ). Finally, we applied WZB117 topically to human psoriatic skin organoids 35 . WZB117 inhibited the expression of several psoriatic biomarkers (CXCL3, PI3 (also known as ELAFIN), DEFB4A (also known as HBD-2), S100A7, and S100A8) in a dose-dependent fashion (Fig. 6g ). Thus, whereas genetic Glut1 deletion rescued only the epidermal acanthosis and proliferation, the topical, chemical inhibition of glucose transport rescued keratinocyte proliferation and also prevented inflammation in animal and organoid models of psoriasiform inflammation.
Discussion
The epidermis is a self-renewing organ that protects the body against environmental insults and excess water loss 36 . How glucose uptake and metabolism contribute to these essential processes has not been explored in vivo. Through the deletion of the Glut1 transporter in keratinocytes, we found that glucose uptake is critical for rapid keratinocyte proliferation and is an efficient response to physiologically relevant stressors including full-thickness wounds and UV-B irradiation. Despite evidence of stressed energy metabolism and oxidative stress in vitro, K14.Glut1 mice showed normal epidermal development. In keratinocytes, in contrast to many other tissues, Glut1 is the only substantially expressed glucose transporter, and its deletion largely abolished glucose transport. Thus, our metabolic analyses of Glut1-deficient keratinocytes have broader implications regarding how other tissues and cancer cells might adapt to a general block of glucose metabolism.
Because glucose contributes to several metabolic pathways, cells induced multiple compensatory pathways in its absence. Our findings highlight the importance of the PPP in the skin, as has previously been demonstrated in vitro 22, 37 . Transcriptional upregulation of many oxidative-stress-response genes was observed in the Glut1deficient keratinocytes. Under conditions of decreased hexose availability, metabolic processes involving central carbon metabolism, including glycolysis, the TCA cycle, and nucleotide synthesis, were suppressed. Transcriptional and metabolomic analyses suggested that alterations in amino acid metabolism might help to maintain these biosynthetic cycles. Specifically, the pattern of alterations in amino acid metabolism may be explained by increased catabolism of specific amino acids to generate ketoacids (for example, α -ketoglutarate from glutamine and α -ketobutyrate from cystathionine) to compensate for the loss of glucose. In addition to alterations in amino acid metabolism, we also found that fatty acids partially rescued proliferative defects in Glut1-deficient keratinocytes. In vitro, alternative hexoses, especially fructose, rescued the proliferative defects of Glut1 deficiency. Despite the low circulating levels of these hexoses 38, 39 , galactose was detected intracellularly in both normal and Glut1-deficient epidermis, thus suggesting that these hexoses may contribute to normal skin development in the absence of glucose. Galactose rescued growth less efficiently than did fructose, a result reflecting either inefficient transport of galactose by non-Glut1 facilitative glucose transporters or limitations in the efficiency of the Leloir pathway in keratinocytes 40, 41 . However, supplementation with other downstream metabolites did not rescue the growth of keratinocytes from K14.Glut1 mice. We speculate that the inherent limitations of in vitro culture systems 42 and the central role of glucose in diverse metabolic and signaling pathways may have limited our ability to rescue the growth of Glut1-deficient keratinocytes.
Although the generation of mitochondria-derived ROS is necessary for skin differentiation 43 , the increased oxidative stress caused by loss of glucose transport does not affect skin differentiation. The glycosylation of both proteins and lipids plays an important biochemical role in the skin. Specifically, glycosylated ceramides have been found to be essential for the proper formation of an intact stratum corneum, because the deletion of glucosylceramide synthase (Ugcg gene) results in a disruption of normal ceramide metabolism, aberrant stratum corneum development, and perinatal lethality 26 . Despite defects in hexosylceramide synthesis in vitro, we found the skin barrier to be intact, thus suggesting that the epidermis is able to maintain sufficient levels of ceramides for the maturation of epidermal ceramides even in the absence of Glut1.
Because glucose uptake is required for proliferating keratinocytes but not for normal skin development and function, our findings suggest that inhibiting glucose transport may be a promising therapy for skin diseases. Antimetabolites that target the heightened biosynthetic requirements of proliferating cells-including methotrexate 44 , 5-fluorouracil 45 , and mycophenolic acid 46 -are some of the most effective treatments for inflammatory and neoplastic diseases. Although most antimetabolite therapies have been discovered fortuitously, our analysis of Glut1 uncovered glucose transport as a potential target. Psoriasis is characterized by excessive cytokine-driven epidermal hyperplasia 47 . Psoriatic lesions have heightened requirements for glucose uptake and metabolism, as evidenced by increased Glut1 expression and positron emission tomography scans 48 . Metabolomic studies have demonstrated elevated serum levels of some amino acids in patients with psoriasis 49, 50 . Our metabolomic analysis of the epidermis of Glut1-deficient mice revealed decreases in a similar set of amino acids. Levels of sphingoid bases were elevated in the serum and skin of patients, in agreement with our finding that levels of these lipids were lower in the skin of Glut1-deficient mice than WT mice 51 . Comparing the metabolomics from patients and from Glut1-deficient mice suggested that inhibiting glucose transport may affect metabolic pathways critical to the development of psoriasis. In agreement with this prediction, Glut1-deficient mice were protected against imiquimod-induced psoriasiform hyperplasia. Although the systemic administration of a glucose-transport inhibitor has been predicted to cause neurologic sequelae, hyperglycemia, and lipodystrophy 21, 52 , these toxicities might be avoided through the topical use of glucose-transport inhibitors. Indeed, the topical application of a Glut1 inhibitor was also effective in protecting mice against imiquimod-induced psoriasiform hyperplasia. Similarly to the deletion of Glut1 in keratinocytes, chemical inhibition of Glut1 inhibited epidermal proliferation and acanthosis. Topical transport inhibitors had the added feature of suppressing inflammatory infiltrates and cytokine secretion in animal models of psoriasis and human psoriatic skin organoids, respectively. In agreement with previously reported roles of Glut1 and glucose metabolism in T lymphocyte activation 20, 53 , we speculate that the topical application of WZB117 might also inhibit glucose uptake in other cell types in the skin, including infiltrating lymphocytes, and thereby limit inflammation in vivo. In summary, our study provides insight into the metabolic reprogramming that allows cells to survive in the absence of glucose metabolism, highlights the role of glucose transport after physiological stressors, and identifies glucose transport as a viable target in hyperproliferative skin diseases. 
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Experimental design 1. Sample size
Describe how sample size was determined.
No statistical methods were used to predetermine sample size.
Data exclusions
Describe any data exclusions.
For the epidermal tissue metabolomite profiling, the Glut1fl/fl control group contained 8 mice, and Glut1fl/fl K14-Cre group contained 8 mice. One mouse in the Glut1fl/fl K14-Cre group showed inefficient Glut1 knockout as assessed by RT-PCR; thus, it was excluded from the data analysis.
Replication
Describe the measures taken to verify the reproducibility of the experimental findings.
For all the cell culture experiments, each experiment was repeated in at least 3 independent experiments. For primary cultured keratinocytes, each independent experiment used cells derived from different mice. All animal experiments (UV irradiation, wound healing, psoriasiform dermatitis) were repeated independently at least 3 times in different groups of mice. For gene expression analyses (microarray), samples were analyzed from a total of 8 mice, with RNA pooled from 2 independent mice. We confirmed the expression of genes of interest by RT-PCR in independent samples from at least 3 independent mice.
Randomization
Describe how samples/organisms/participants were allocated into experimental groups.
For primary cultured mouse keratinocytes, we isolated keratinocytes from littermates and determined the genotype of each cell line and confirmed the genotype by RT-PCR or Western blot after samples were collected or the experiments were completed. For mouse experiments, Glut1fl/fl females were crossed with Glut1fl/fl K14-Cre male which allowed for the gnerattion of similar ratios of WT and conditional KO mice mice. Mice were gender and age matched for experiments. For experiments, gender and age matched mice were randomly allocated into groups for for the experiments.
Blinding
Describe whether the investigators were blinded to group allocation during data collection and/or analysis.
For allocation into groups, treatments, and data collection, investigators were blinded to the genotypes of the mice. For all histological analyses, the rater was blinded to the genotype and/or and treatment condition. Note: all in vivo studies must report how sample size was determined and whether blinding and randomization were used.
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Statistical parameters
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the Methods section if additional space is needed). n/a Confirmed The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided Only common tests should be described solely by name; describe more complex techniques in the Methods section.
A description of any assumptions or corrections, such as an adjustment for multiple comparisons Test values indicating whether an effect is present Provide confidence intervals or give results of significance tests (e.g. P values) as exact values whenever appropriate and with effect sizes noted.
A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars in all relevant figure captions (with explicit mention of central tendency and variation)
See the web collection on statistics for biologists for further resources and guidance.
Software
Policy information about availability of computer code
Describe the software used to analyze the data in this study.
GraphPad Prism Version 7.0A MetaboAnalyst 3.0 (http://www.metaboanalyst.ca/) Affymetrix Expression Console Software (https://www.thermofisher.com/us/en/home/lifescience/microarray-analysis/microarray-analysis-instruments-software-services/microarrayanalysis-software/affymetrix-transcriptome-analysis-console-software.html) For manuscripts utilizing custom algorithms or software that are central to the paper but not yet described in the published literature, software must be made available to editors and reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). Nature Methods guidance for providing algorithms and software for publication provides further information on this topic.
Materials and reagents
Policy information about availability of materials
Materials availability
Indicate whether there are restrictions on availability of unique materials or if these materials are only available for distribution by a third party.
